Nutraceutical News and Research

RSS

Nutraceutical, a portmanteau the words “nutrition” and “pharmaceutical”, is a food or food product that provides health and medical benefits, including the prevention and treatment of disease.

PharmaVentures acts as advisor and broker to Dr Reddy's in distribution agreement with Vitabiotics

PharmaVentures Ltd announced today that it had acted as the advisor and broker to the Indian pharmaceutical company Dr Reddy's Laboratories in its successful marketing and distribution agreement with the UK healthcare company Vitabiotics Ltd for a range of nutraceutical products. The agreement provides Dr Reddy's exclusive marketing rights in the Russian/CIS markets for two of Vitabiotics' leading products - Jointace and Dietrim. Vitabiotics will supply these products on a long-term basis from its facilities in Europe.

From Vitabiotics Ltd. 26 Oct 2010

Neptune second quarter revenue increases 200% to $4,114,000

Neptune Technologies & Bioressources Inc. today reports its consolidated financial results for the three and six-month periods ended August 31, 2010.

15 Oct 2010

DSM project on carbon dioxide footprint reduction receives European Outsourcing Awards

DSM Pharmaceutical Products, the custom manufacturing organization of Royal DSM NV, is pleased to announce that their submission for the European Outsourcing Awards, organized by Via Media UK Ltd, entitled Achieving substantial carbon dioxide footprint reduction for the scale up of a drug intermediate was an award recipient at the 6th October ceremony held in Paris, France.

7 Oct 2010

Soy germ-based nutritional supplement helps to manage menopausal symptoms

A new women-s health, whole soy germ-based nutritional supplement containing Natural S-equol reduced the frequency of moderate to severe hot flashes and reduced muscle and joint pain in the first study of its kind among postmenopausal U.S. women, according to peer-reviewed data presented as a poster presentation at the North American Menopause Society (NAMS) Annual Meeting.

7 Oct 2010

Oxy-Powder supplement clears clinical trials for Irritable Bowel Syndrome

The popular nutraceutical health supplement, Oxy-Powder has passed clinical trials for Irritable Bowel Syndrome (IBS) with a 99.9 percent success rate.According to the NIH, approximately 20% of Americans suffer from the symptoms of IBS, which qualifies it as one of the most common medical problems in the United States.

21 Sep 2010

Sorghum bran contains high antioxidant, anti-inflammatory properties: Study

A new University of Georgia study has found that select varieties of sorghum bran have greater antioxidant and anti-inflammatory properties than well-known foods such as blueberries and pomegranates.

14 Sep 2010

Researchers discover first compound to activate enzyme telomerase in human body

Sierra Sciences, in collaboration with TA Sciences, Geron Corporation, PhysioAge, and the Spanish National Cancer Research Center (CNIO), has announced the first compound ever discovered that activates the enzyme telomerase in the human body - a critical prerequisite for technology that could arrest or reverse the aging process in humans.

9 Sep 2010

Irving Place Capital signs agreement to acquire Alpha Packaging

Irving Place Capital, a middle-market private equity firm, announced today that it has signed a purchase agreement to acquire Alpha Packaging, a leading blow molder of plastic bottles and jars for the nutraceutical, pharmaceutical and personal care markets. IPC is investing in partnership with Alpha's current management team, led by President and Chief Executive Officer Dave Spence and Chief Operating Officer Dan Creston. The transaction is expected to close in September of 2010.

31 Aug 2010

Vitamin D2 in AbM mushroom can neutralize oxidative stress: Research

Total Nutraceutical Solutions, Inc., announced that it has completed a research study comparing the therapeutic effect of single nutrient forms of synthetic Vitamin D3 and D2 versus natural Vitamin D2 within a whole food. The study focused on the control of Paraquat induced oxidative stress/biologic death.

25 Aug 2010

OXIS International to introduce new ergothioneine-based products for joint health and healthy aging

OXIS INTERNATIONAL, INC. is proud to announce that it will introduce the benefits of Ergothioneine to the consumer market in September 2010 via breakthrough products for joint health and healthy aging. The first products, ErgoFlex® and ErgoPlex®, will initially be marketed via a direct mail offering being developed in partnership with Creative Direct Marketing Group, the leading service provider in the direct mail sector of the direct to consumer channel.

25 Aug 2010

Nutrastar second-quarter revenues increase 63.4% to $5.46 million

Nutrastar International Inc., a leading nutraceutical company which produces and distributes Chinese Golden Grass and other specialty food products, today announced financial results for their three and six months ended June 30, 2010.

16 Aug 2010

Bellus Health reports net loss of $5.8M for second-quarter vs. net income of $14.27M for previous year

BELLUS Health Inc. reported today its financial results for the second quarter ended June 30, 2010. The Company also announced new initiatives to reduce its annual expenditures ("burn rate") by focusing its efforts on existing products and on supporting current and future strategic partnerships. All currency figures reported in this press release, including comparative figures, are in Canadian dollars, unless otherwise specified.

9 Aug 2010

American Oriental Bioengineering second-quarter revenue up 8.5%

American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced financial results for the second quarter ended June 30, 2010.

9 Aug 2010

Colorcon acquires business of Pharmaceutical Coatings

Colorcon, Inc. today announced the acquisition of the business of Pharmaceutical Coatings Pvt. Ltd. (India) which includes the company's full product portfolio, plus a new facility in Goa that is currently under construction.

26 Jul 2010

Canon Communications to redesign NutritionalOutlook for quick access to relevant content

Today, at the IFT Annual Meeting and Food Expo, the largest annual food science forum and exposition in the world, Canon Communications LLC announced it is in the process of a redesign of NutritionalOutlook.com, the leading online resource for manufacturers of dietary supplements and healthy foods. The website redesign, featuring new content, qualified supplier search, community-building tools, and nutraceutical industry resources, will launch in fall 2010.

22 Jul 2010

DBS signs exclusive license agreement with JLB

Decas Botanical Synergies, LLC. today announced that it has signed an Exclusive License Agreement with a purchase option with JLB, Inc. developer and owner of broad-based patents covering cranberry and other vaccinium species.

20 Jul 2010

Neptune first-quarter 2010 revenue up by 45% to $4,162,000

Neptune Technologies & Bioressources Inc. today reports its consolidated financial results for the three-month period ended May 31, 2010, appoints IR firm and updates on options and warrants.

14 Jul 2010

Natrol offers two new beauty nutraceuticals that provide anti-aging skin and hair support for women

Most dermatologists would agree that premature skin aging can result from sun over-exposure, poor antioxidant intake, and excess free-radical production. Additionally, regarding hair health, about 20 million U.S. women experience premature hair-loss and hair-thinning. Natrol, Inc., a premier marketer, manufacturer, and distributor of nationally branded nutritional products, now offers two new beauty nutraceuticals that help provide anti-aging skin and hair support for women -- one dietary supplement helps optimize skin radiance via antioxidant protection for the skin, and another helps maximize follicular growth for hair.

9 Jul 2010

Neptune Technologies & Bioressources not to proceed with private placement

Neptune Technologies & Bioressources Inc. announces that, due to market conditions, it will not be proceeding with the private placement as announced in a news release dated May 4, 2010.

17 Jun 2010

CBIS shares owned by Cannex Therapeutics to be cancelled and re-issued to K&D

Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products announces Federal Court order for CBIS shares owned by Cannex Therapeutics controlled by Steve Kubby to be cancelled and re-issued to K&D. Both K&D and Cannabis Science denounce the "slanderous, malicious attacks" on the Company by its fired CEO Steve Kubby.

15 Jun 2010